Healthy volunteers help test how drug BI 655130 moves through the body
NCT ID NCT03100903
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This early-stage study looked at how a new drug called BI 655130 enters the bloodstream when given as a shot under the skin compared to through an IV. Thirty-six healthy adults took part. The goal was not to treat any disease, but to understand the drug's safety and how the body processes it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.